Fermitin 2 Protein (Kindlin 2) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
[^1]
[^2]
[^3]
| Protein Name | Fermitin-2 (Kindlin-2) |
|---|
| Gene Symbol | FERMT2 |
|---|
| UniProt ID | Q9N3I2 |
|---|
| PDB Structure IDs | 5H9R, 6O9Z |
|---|
| Molecular Weight | ~76 kDa |
|---|
| Subcellular Localization | Plasma membrane, Cytoplasm, Focal adhesions |
|---|
| Protein Family | Fermitin family (Kindlin family) |
|---|
Fermitin-2, also known as Kindlin-2, is a member of the fermitin/kindlin family of proteins that play critical roles in integrin activation and cell-matrix adhesion. Fermitin-2 is widely expressed in various tissues including the brain, where it regulates integrin-mediated signaling important for neuronal survival and blood-brain barrier (BBB) function.[1]
Fermitin-2 is a 683 amino acid protein with a characteristic domain architecture:
- N-Terminal FERM Domain: Contains subdomains F1, F2, and F3 (4.1/ezrin/radixin/moesin homology) that mediate protein-protein and protein-lipid interactions
- PH Domain: Pleckstrin homology domain for membrane localization through phosphoinositide binding
- Proline-Rich Region: Contains binding sites for SH3 domain-containing proteins
The FERM domain binds to integrin β cytoplasmic tails, while the PH domain targets the protein to the plasma membrane.
Fermitin-2/Kindlin-2 performs essential functions:
- Cooperates with talin to activate integrins by binding to integrin β cytoplasmic tails[2]
- Induces conformational changes that increase integrin affinity for extracellular matrix ligands
- Essential for inside-out integrin signaling
- Critical for formation and maintenance of focal adhesions
- Links integrins to the actin cytoskeleton
- Regulates focal adhesion turnover during cell migration
- Expressed in endothelial cells where it regulates BBB integrity
- Present in neurons where it may influence synaptic function
- Involved in astrocyte-endothelial interactions
FERMT2 has been identified as a genetic risk factor for late-onset Alzheimer's disease (LOAD) through GWAS.[3]
Disease Mechanisms:
- Blood-Brain Barrier: Fermitin-2 in endothelial cells may regulate BBB integrity; variants could affect BBB dysfunction in AD[4]
- Neuroinflammation: Modulates microglial adhesion and migration to sites of pathology
- Synaptic Adhesion: Integrin-mediated adhesion at synapses; fermitin-2 may affect synaptic stability
Fermitin-2 is frequently overexpressed in various cancers and is associated with tumor progression and metastasis.
Strategies for targeting fermitin-2 in AD:
- BBB Protection: Developing compounds that enhance endothelial fermitin-2 function to maintain BBB integrity
- Integrin Modulation: Targeting integrin-fermitin-2 interactions to improve neuronal survival
- Anti-inflammatory: Modulating microglial adhesion and migration
The study of Fermitin 2 Protein (Kindlin 2) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.